Feb 28, 2019 - Wider-than-expected loss affects Aduro (ADRO) in the fourth quarter. Also, revenues lag estimates.
Feb 28, 2019 - United Therapeutics (UTHR) beats estimates for both earnings and sales in the fourth quarter. Stock up.
Feb 26, 2019 - Corcept (CORT) earnings beat estimates in the fourth quarter of 2018 on increased revenues.
Feb 22, 2019 - Merck (MRK) plans to acquire Immune Design for $300 million in cash. Merck will pay $5.85 in cash for each share of Immune Design.
Feb 22, 2019 - Merck (MRK) to buy Immune Design for $300 million. FDA grants priority review to regulatory applications filed by Merck, Roche (RHHBY) and AbbVie (ABBV).
Feb 22, 2019 - The index endured a holiday-shortened but volatile week.
Feb 20, 2019 - Allergan (AGN) informs that it does not agree with the view of its key shareholder, Appaloosa, to separate the roles of CEO and board chairman.
Feb 19, 2019 - Eli Lilly and Co (LLY) Files 10-K for the Fiscal Year Ended on December 31, 2018, Stocks: LLY, release date:Feb 19, 2019
Feb 19, 2019 - Bayer (BAYRY) obtains full exclusive licensing rights for the global development and commercialization of Vitrakvi (larotrectinib) and BAY 2731954 (LOXO-195) from Loxo.
Feb 15, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eli Lilly (LLY) have what it takes? Let's find out.